Saudi Arabia Blood Glucose Device Market Size & Forecast (2025–2033)

According to Renub Research Saudi Arabia Blood Glucose Device Market is set for consistent expansion, rising from US$ 143.96 million in 2024 to nearly US$ 259.8 million by 2033, registering a CAGR of 6.78% throughout the forecast period. The market’s acceleration is strongly tied to the rising prevalence of diabetes, the growing focus on preventive healthcare, and the increasing availability of modern glucose monitoring technologies such as continuous glucose monitoring (CGM) systems and user-friendly glucometers. Awareness campaigns, government-driven health reforms, and improved access to diagnostic tools are further supporting large-scale adoption of blood glucose devices across the Kingdom.

Saudi Arabia Blood Glucose Device Market Overview

Blood glucose monitoring devices are essential medical tools used to measure the concentration of glucose in the blood. For individuals diagnosed with diabetes—whether Type 1, Type 2, or gestational—these devices play a vital role in disease management, enabling early detection of abnormal glucose levels and helping prevent complications such as hypoglycemia, hyperglycemia, cardiovascular issues, and kidney damage. The most common devices include glucometers, continuous glucose monitoring systems, and flash glucose monitors, each providing real-time or periodic readings.

In Saudi Arabia, the demand for blood glucose monitoring systems has grown substantially due to the alarming rise in diabetes rates, which has become one of the nation’s primary public health concerns. Sedentary lifestyles, high-calorie diets, and increasing obesity levels continue to intensify the problem. In response, the government, healthcare providers, and private sector stakeholders are pushing for wider awareness of diabetes management, early diagnosis, and patient self-monitoring. Additionally, easy availability of monitoring devices through pharmacies, e-commerce channels, and hospital clinics has enabled widespread penetration across both urban and rural regions.

Key Growth Drivers in the Saudi Arabia Blood Glucose Device Market

1. Rising Prevalence of Type 2 Diabetes

Saudi Arabia ranks among the countries with the highest diabetes prevalence in the world. The widespread occurrence of Type 2 diabetes is the strongest driver of the blood glucose monitoring device market. The International Diabetes Federation (IDF) reports that 4.27 million Saudis currently live with diabetes, while another 1.86 million remain undiagnosed. These numbers are projected to climb dramatically, reaching 5.6 million by 2030 and 7.5 million by 2045, placing enormous pressure on the healthcare system.

This rapid rise in diabetes cases has encouraged both patients and caregivers to adopt regular glucose monitoring as part of routine self-care. Increased public awareness, government-funded screening programs, and preventive health initiatives have further strengthened demand for glucose monitoring tools. As more individuals adopt early management strategies, the market is expected to witness sustained growth in the coming decade.

2. Advancement of Monitoring Technologies

Technological innovation is profoundly shaping the Saudi blood glucose device landscape. Traditional glucometers are now accompanied by CGM devices, Bluetooth-enabled meters, non-invasive wearables, and systems that offer smartphone integration. These modern solutions provide superior accuracy, easier usability, and the convenience of real-time glucose tracking.

A key development occurred in August 2023, when Nemaura Medical received SFDA approval for SugarBEAT, a non-invasive wearable glucose sensor that offers continuous glucose insights without the need for finger pricks. Such innovations are improving patient comfort, engagement, and compliance, especially among young adults and tech-savvy consumers. Continued entry of international manufacturers and increased distribution of advanced products will further elevate market growth.

3. Strong Government Initiatives and Public Health Campaigns

Saudi Arabia’s Vision 2030 health transformation plan places heavy emphasis on preventive healthcare, chronic disease management, and enhanced quality of life. Under this strategic framework, the government promotes early diabetes detection and widespread access to glucose monitoring devices.

National diabetes screening programs, awareness drives in schools and workplaces, and partnerships with healthcare organizations support early diagnosis. Insurance coverage for diabetes care and subsidies for essential medical equipment encourage broad adoption of monitors, especially among low-income patients. Hospitals and primary healthcare centers across the Kingdom are equipped with modern monitoring devices to support newly diagnosed individuals.

In 2024, the Ministry of Health partnered with Ithnain to introduce advanced diabetes coaching programs benefiting more than 10,000 patients, reflecting Saudi Arabia’s commitment to strengthening diabetes management across the population.

Market Challenges

1. High Cost of Advanced Monitoring Devices

Although CGMs and smart glucometers offer superior functionality, their high cost remains a major restraint. Many patients still rely on basic meters due to limited insurance coverage or budget constraints. Premium devices with continuous monitoring features may remain inaccessible for low- and middle-income consumers unless broader subsidy programs are implemented.

2. Limited Awareness and Compliance in Rural Areas

Despite strong healthcare infrastructure in major cities, rural regions often struggle with limited diabetes awareness and uneven access to modern devices. Some patients lack education on proper usage, while others are hesitant to adopt newer technologies. These disparities impede early diagnosis and effective long-term disease management, indicating the need for targeted education initiatives and better regional distribution channels.

Saudi Arabia Blood Glucose Device Market by Product

Test Strips

Test strips account for a substantial share of the Saudi blood glucose device market. Their affordability, simplicity, and compatibility with standard glucometers make them widely preferred, particularly among older adults and Type 2 diabetes patients. However, recurring expenses associated with test strips may burden long-term users. Continuous supply from global and domestic manufacturers ensures stable growth in this segment.

Lancets and Glucometers

Lancets and standard glucometers remain the primary choice for daily diabetic management. Their low cost, availability in all pharmacies, and ease of use help maintain strong demand. Glucometers with large displays, minimal blood requirements, and smartphone connectivity are increasingly popular among elderly users and caregivers.

Saudi Arabia Blood Glucose Device Market by Application

Type 2 Diabetes

Type 2 diabetes represents the largest application segment for blood glucose monitoring devices. Continuous monitoring is essential for therapeutic adjustments, preventing complications, and maintaining healthy glucose levels. With rising prevalence and increased emphasis on home-based monitoring, the market for Type 2 diabetes monitoring devices is expected to grow rapidly.

Type 1 Diabetes and Gestational Diabetes

Type 1 diabetes patients frequently rely on CGMs and accurate glucometers to manage insulin intake. Pregnant women experiencing gestational diabetes also require strict glucose monitoring to prevent complications for both mother and child, supporting growth in these segments.

Saudi Arabia Blood Glucose Device Market by End User

Hospital Pharmacies

Hospital pharmacies serve as foundational distribution points for newly diagnosed patients. They provide device training, demonstrations, and clinical support. Public hospitals often distribute devices at subsidized prices, ensuring equitable access.

Retail Pharmacies

Retail pharmacies, including Al Nahdi, Al-Dawaa, and White Pharmacy, represent one of the largest distribution channels. Their wide footprint, patient education services, and loyalty programs make them preferred outlets for glucose monitoring devices. Online ordering and home delivery offerings further improve accessibility.

Online Sales & Diabetes Clinics

E-commerce platforms are increasingly preferred by tech-savvy consumers for purchasing devices and related supplies. Diabetes clinics and specialized centers also contribute significantly to the market by offering comprehensive monitoring and education programs.

Regional Insights

Dhahran

Dhahran, with its affluent demographic and advanced healthcare facilities, exhibits high adoption of modern CGM systems and wearable glucose monitors. Educational campaigns and active involvement of private clinics support strong market growth.

Riyadh

Riyadh is the largest and most influential market due to its dense healthcare infrastructure, advanced diagnostic centers, and tech-oriented population. Vision 2030 health initiatives are actively implemented here, contributing to rising adoption of smart glucose monitoring solutions.

Jeddah

Jeddah’s growing incidence of lifestyle-related diseases and its diverse population support strong demand for both basic and advanced monitoring devices. The city’s digital health initiatives and awareness campaigns enhance market penetration.

Market Segmentation Overview

Product:
– Test Strips
– Lancets
– Blood Glucose Meters

Application:
– Type 1 Diabetes
– Type 2 Diabetes
– Gestational Diabetes

End User:
– Hospital Pharmacies
– Retail Pharmacies
– Online Sales
– Diabetes Clinics & Centers

Top Regions:
Dhahran, Riyadh, Khobar, Jeddah, Dammam, and Others

Key Companies

Leading players in the Saudi Arabia blood glucose device market include:
Abbott Laboratories, Medtronic, Dexcom Inc., B. Braun Melsungen AG, DarioHealth Corp, Sanofi, Bionime Corporation, and Novo Nordisk.